GlassScriptPhysician profile
Wesley A Tyree
NPI 1699975011
$10,103.93
in general payments reported to CMS, 2019-2025
40 companies · $1,051 in 2025
The $1,051 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,764 · 2020: $859 · 2021: $1,311 · 2022: $1,221 · 2023: $2,104 · 2024: $1,793 · 2025: $1,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,947.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,478.38 | 2021-2025 | |
| Medtronic, INC. | $1,225.50 | 2021-2025 | Micra, Corevalve Evolut R, Aurora Ev-Icd Mri Surescan |
| Janssen Pharmaceuticals, INC | $1,202.24 | 2019-2024 | Xarelto |
| Amgen INC. | $901.90 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $647.20 | 2019-2023 | Assurity, Cardiomems |
| Medtronic Vascular, INC. | $497.17 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $471.22 | 2021-2025 | Verquvo, Capvaxive |
| Pfizer INC. | $439.38 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $417.43 | 2019-2025 | Lifevest |
| Atricure, INC. | $373.94 | 2023-2024 | |
| Philips North America LLC | $277.10 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.81 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $183.55 | 2019-2025 | General - Vascular Intervention |
| Bardy Diagnostics, INC. | $165.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $157.43 | 2019-2025 | Camzyos |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Tyree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.